SYK

StrykerNYSE:SYK Stock Report

Market Cap

US$103.0b

7D

-0.3%

1Y

32.3%

Updated

19 Sep, 2021

Data

Company Financials +
SYK fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance3/6
Financial Health3/6
Dividends4/6

SYK Overview

Stryker Corporation operates as a medical technology company.

Share Price & News

How has Stryker's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SYK is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: SYK's weekly volatility (2%) has been stable over the past year.


Market Performance


7 Day Return

-0.3%

SYK

-0.4%

US Medical Equipment

-0.6%

US Market


1 Year Return

32.3%

SYK

34.6%

US Medical Equipment

33.8%

US Market

Return vs Industry: SYK underperformed the US Medical Equipment industry which returned 34.6% over the past year.

Return vs Market: SYK underperformed the US Market which returned 33.8% over the past year.


Shareholder returns

SYKIndustryMarket
7 Day-0.3%-0.4%-0.6%
30 Day2.9%2.5%2.0%
90 Day5.1%11.6%4.7%
1 Year33.7%32.3%35.6%34.6%35.8%33.8%
3 Year61.8%56.5%69.1%65.2%60.0%50.1%
5 Year145.8%131.9%161.6%149.7%123.0%98.7%

Long-Term Price Volatility Vs. Market

How volatile is Stryker's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Stryker Fundamentals Summary

How do Stryker's earnings and revenue compare to its market cap?
SYK fundamental statistics
Market CapUS$102.96b
Earnings (TTM)US$2.08b
Revenue (TTM)US$16.25b

49.4x

P/E Ratio

6.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SYK income statement (TTM)
RevenueUS$16.25b
Cost of RevenueUS$5.59b
Gross ProfitUS$10.65b
ExpensesUS$8.57b
EarningsUS$2.08b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)5.54
Gross Margin65.57%
Net Profit Margin12.82%
Debt/Equity Ratio92.2%

How did SYK perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

45%

Payout Ratio

Does SYK pay a reliable dividends?

See SYK dividend history and benchmarks
When do you need to buy SYK by to receive an upcoming dividend?
Stryker dividend dates
Ex Dividend DateSep 29 2021
Dividend Pay DateOct 29 2021
Days until Ex dividend9 days
Days until Dividend pay date39 days

Does SYK pay a reliable dividends?

See SYK dividend history and benchmarks

Valuation

Is Stryker undervalued compared to its fair value and its price relative to the market?

49.43x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: SYK ($273.03) is trading above our estimate of fair value ($239.11)

Significantly Below Fair Value: SYK is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SYK is good value based on its PE Ratio (49.4x) compared to the US Medical Equipment industry average (53.4x).

PE vs Market: SYK is poor value based on its PE Ratio (49.4x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: SYK is poor value based on its PEG Ratio (2.2x)


Price to Book Ratio

PB vs Industry: SYK is overvalued based on its PB Ratio (7.4x) compared to the US Medical Equipment industry average (4.8x).


Future Growth

How is Stryker forecast to perform in the next 1 to 3 years based on estimates from 28 analysts?

23.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SYK's forecast earnings growth (23% per year) is above the savings rate (2%).

Earnings vs Market: SYK's earnings (23% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SYK's revenue (6.6% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: SYK's revenue (6.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SYK's Return on Equity is forecast to be high in 3 years time (23.2%)


Past Performance

How has Stryker performed over the past 5 years?

6.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SYK has a large one-off loss of $904.0M impacting its June 30 2021 financial results.

Growing Profit Margin: SYK's current net profit margins (12.8%) are higher than last year (11.4%).


Past Earnings Growth Analysis

Earnings Trend: SYK's earnings have grown by 6% per year over the past 5 years.

Accelerating Growth: SYK's earnings growth over the past year (30.1%) exceeds its 5-year average (6% per year).

Earnings vs Industry: SYK earnings growth over the past year (30.1%) underperformed the Medical Equipment industry 40.5%.


Return on Equity

High ROE: SYK's Return on Equity (15.1%) is considered low.


Financial Health

How is Stryker's financial position?


Financial Position Analysis

Short Term Liabilities: SYK's short term assets ($9.0B) exceed its short term liabilities ($4.3B).

Long Term Liabilities: SYK's short term assets ($9.0B) do not cover its long term liabilities ($15.6B).


Debt to Equity History and Analysis

Debt Level: SYK's debt to equity ratio (92.2%) is considered high.

Reducing Debt: SYK's debt to equity ratio has increased from 83.9% to 92.2% over the past 5 years.

Debt Coverage: SYK's debt is well covered by operating cash flow (26.7%).

Interest Coverage: SYK's interest payments on its debt are well covered by EBIT (10.7x coverage).


Balance Sheet


Dividend

What is Stryker current dividend yield, its reliability and sustainability?

0.92%

Current Dividend Yield


Upcoming Dividend Payment

TodaySep 20 2021Ex Dividend DateSep 29 2021Dividend Pay DateOct 29 202130 days from Ex DividendBuy in the next 9 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: SYK's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).

High Dividend: SYK's dividend (0.92%) is low compared to the top 25% of dividend payers in the US market (3.6%).


Stability and Growth of Payments

Stable Dividend: SYK's dividends per share have been stable in the past 10 years.

Growing Dividend: SYK's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (44.5%), SYK's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: SYK's dividends in 3 years are forecast to be well covered by earnings (25.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Kevin Lobo (56 yo)

8.92yrs

Tenure

US$13,317,032

Compensation

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012. He serves as Chairman of the Board at The Advanced Medical Technology Association (AdvaMed). He serves a...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD13.32M) is about average for companies of similar size in the US market ($USD11.33M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SYK's management team is considered experienced (3.3 years average tenure).


Board Members

Experienced Board: SYK's board of directors are considered experienced (4.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SYK insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Stryker Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Stryker Corporation
  • Ticker: SYK
  • Exchange: NYSE
  • Founded: 1941
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$102.959b
  • Shares outstanding: 377.10m
  • Website: https://www.stryker.com

Number of Employees


Location

  • Stryker Corporation
  • 2825 Airview Boulevard
  • Kalamazoo
  • Michigan
  • 49002
  • United States

Listings


Biography

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants f...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/19 22:02
End of Day Share Price2021/09/17 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.